Compare TSEM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSEM | BNTX |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Israel | Germany |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7B | 24.2B |
| IPO Year | 1996 | 2019 |
| Metric | TSEM | BNTX |
|---|---|---|
| Price | $245.14 | $93.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $161.75 | $133.46 |
| AVG Volume (30 Days) | ★ 1.7M | 945.8K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.21 | N/A |
| Revenue Next Year | $26.62 | $3.37 |
| P/E Ratio | $66.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $43.12 | $79.81 |
| 52 Week High | $319.94 | $124.00 |
| Indicator | TSEM | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.64 | 56.87 |
| Support Level | $111.97 | $90.95 |
| Resistance Level | $293.16 | $94.20 |
| Average True Range (ATR) | 17.73 | 2.29 |
| MACD | -4.19 | 0.68 |
| Stochastic Oscillator | 13.99 | 86.91 |
Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs) based on the design specifications of customers. The company's line of integrated circuits is incorporated into markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.